Login / Signup
María Reviejo
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Combination Therapy
Systematic Review
Advanced Non Small Cell Lung Cancer
Tyrosine Kinase
Top Venues
Clinical pharmacology and therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tania Payo-Serafín
,
Carolina Méndez-Blanco
,
Paula Fernández-Palanca
,
Jennifer Martínez-Geijo
,
María Reviejo
,
Juan José Ortiz-de-Urbina
,
Javier Gonzalez-Gallego
,
Jose J G Marin
,
José Luis Mauriz
,
Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Clinical pharmacology and therapeutics
116 (2) (2024)
Tania Payo-Serafín
,
Carolina Méndez-Blanco
,
Paula Fernández-Palanca
,
Jennifer Martínez-Geijo
,
María Reviejo
,
Juan José Ortiz-de-Urbina
,
Javier Gonzalez-Gallego
,
Jose J G Marin
,
José Luis Mauriz
,
Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Clinical pharmacology and therapeutics
(2024)